
Our newly published whitepaper presents comprehensive research supporting the efficacy and safety of Vision Protection Therapy™.
Drawing from decades of clinical use and laboratory studies, the paper outlines the science, methodology, and transformative potential of this non-damaging, repeatable therapy for treating progressive retinal diseases. It offers valuable insights for clinicians, researchers, and anyone interested in the future of vision care.
Download the whitepaper to dive into the data and discover how SAPRA™ is shaping the next frontier in retinal treatment.
Whitepaper
SAPRA™ is the first device designed perform modern retinal laser therapy, epitomized by SDM™ Vision Protection Therapy™
Treatment is non-invasive and safe; Locked parameters and built-in redundancies to further eliminate risk of harm from incorrect use
Simple & intuitive GUI and industrial design eliminates non-core elements of traditional lasers enabling providers to treat using SAPRA™ after only minutes of training by using a simple point-and-shoot approach to treatment application, akin to taking a cell phone photo
SAPRA™ is designed to maximize patient comfort. Non-contact optics eliminate the need for corneal contact lenses, eye drops or dilation. Treatment takes only seconds. Human factors engineering enhances patient accessibility and comfort, fostering compliance with the Vision Protection Therapy™ treatment program of regular periodic SDM™ designed to maintain the benefits of treatment initially and over a period of time.

Age-Related Macular Degeneration Studies
Diabetic Macular Edema
Macular Edema
Open-Angle Glaucoma
Central Serous Chorioretinopathy
Macular Edema after Retinal Vein Occlusions
Proliferative Diabetic Retinopathy Studies
Inherited Retinal Degenerations